RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise against Tough-to-Treat blood cancer
Disease control CompletedThis study tested the safety and early effectiveness of two different drug combinations for people with an aggressive type of lymphoma that had returned or stopped responding to prior treatments. It involved 53 patients who were not eligible for stem cell transplant. The main goa…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 04, 2026 04:50 UTC
-
New pill tested for Tough-to-Treat blood cancer
Disease control CompletedThis study tested whether a pill called zanubrutinib could help adults with a specific type of aggressive lymphoma that had returned or stopped responding to prior treatments. The trial focused on people whose cancer had a particular genetic change (CD79B mutation). Participants …
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC